Skip to main content

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD.

Himeda CL, Jones TI, Jones PL
Mol Ther Methods Clin Dev. 2020 Dec 10;20:298-311. doi: 10.1016/j.omtm.2020.12.001. eCollection 2021 Mar 12. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article